RetaCalc
Protocol library
SingleApproved OtherMixedModerate confidenceSourced

Gonadorelin

Synthetic GnRH with specialist diagnostic and pulsatile fertility evidence. Clinical schedules rely on pumps, endocrine monitoring and indication-specific adjustment.

Evidence context, not a personal protocol

Quantities below reproduce their stated source context—label, human study, laboratory work or educational guide. They do not assess suitability, product equivalence or individual risk.

Dosage and protocol evidence

Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.

Evidence Gap
People with hypogonadotropic infertility in specialist care

Pulsatile subcutaneous or intravenous GnRH studied at 5 micrograms per pulse every 120 minutes with monitored adjustment

The review describes pump-based fertility treatment and response-guided changes, not manual intermittent injections.

View source

Evidence summary

Synthetic GnRH with specialist diagnostic and pulsatile fertility evidence. Clinical schedules rely on pumps, endocrine monitoring and indication-specific adjustment.

Protocol basis

The evidence supports diagnostic boluses and pump-generated pulses in narrowly defined endocrine settings. A vial calculator cannot reproduce the monitoring or delivery system.

What remains uncertain

Current product availability and authorised indications vary by jurisdiction; retail research vials are not automatically equivalent to labelled medicines.

Warnings and contraindications

Pulsatile gonadorelin therapy requires specialist fertility or endocrine supervision.
Bolus diagnostic use and pump-based fertility treatment are different protocols.
Ovarian response, pregnancy risk and pituitary function require clinical monitoring.